Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ziprasidone mesylate trihydrate

Ziprasidone mesylate trihydrate is an orally active antagonist of dopamine D2 and serotonin 5-HT2A/1A receptors, with respective Ki values of 4.8 nM, 0.42 nM, and 3.4 nM in rats. This compound is widely used in preclinical research to investigate antipsychotic mechanisms in both in vitro binding assays and in vivo behavioral models.

Product Specifications

CAS Number

199191-69-0

Field of Research

Neuroscience, Pharmacology & Drug Discovery

Smiles

O=C1NC2=CC (Cl) =C (CCN3CCN (CC3) C4=NSC5=C4C=CC=C5) C=C2C1.O=S (O) (C) =O.O.O.O

Molecular Formula

C22H31ClN4O7S2

Molecular Weight

563.08

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Eef2k, NT (Eef2k, Eukaryotic elongation factor 2 kinase, Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) (FITC) discontinued
034930-FITC 200 µL

Eef2k, NT (Eef2k, Eukaryotic elongation factor 2 kinase, Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) (FITC) discontinued

Sign In for Pricing
View Details
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
EB30998-01 50 mg

5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside

Sign In for Pricing
View Details
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
EB30998-02 100 mg

5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside

Sign In for Pricing
View Details
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
EB30998-03 200 mg

5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside

Sign In for Pricing
View Details
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
EB30998-04 500 mg

5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside

Sign In for Pricing
View Details
5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside
EB30998-05 1000 mg

5-Bromo-6-chloro-1H-indol-3-yl-a-D-mannopyranoside

Sign In for Pricing
View Details